Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation
BLOOD CELL THERAPY / The official journal of APBMT · 2020
DOI: 10.31547/bct-2019-011 ↗Kurz gefasst
Fachartikel in der Zeitschrift BLOOD CELL THERAPY / The official journal of APBMT, 2020. Verfasst von Minako Iida und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine,Nagakute, Japan. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
By evaluating risks of late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation (HSCT) in Japan, we clarified what we should focus on during follow-up to reduce them. The study cohort included 6,780 patients who had survived for ≥2 years after the first autologous HSCT performed from 1974 to 2012 for hematological diseases. With a median follow-up of 6.0 years among survivors, overall survival probabilities at 5 and 10 years after HSCT were 92% and 83%, respectively. Eight hundred thirty deaths occurred: 451, recurrent primary diseases; 87, subsequent solid cancers; 57, subsequent hematological malignancies; 55, infections; 41, respiratory diseases; 19, cardiovascular diseases; 15, liver diseases; 10, neurological diseases; and 7, kidney/genitourinary diseases (Except small numbers of other causes and missing). According to the log-rank test, the risk of overall mortality was remarkably increased among HSCT recipients compared with the that in the general Japanese population (observed/expected ratio [O/E]=5.4; 95% confidence interval [CI], 5.0-5.8). The risks of cause-specific mortality increased with infection (O/E=6.8; 95% CI, 5.1-8.8), subsequent solid cancers (O/E=1.4; 95% CI, 1.1-1.7), subsequent hematological malignancies (O/E=14.3; 95% CI, 10.8-18.5), kidney/genitourinary diseases (O/E=3.4; 95% CI, 1.4-7.1), respiratory disease (O/E=9.0; 95% CI, 6.5-1.2), and liver diseases (O/E=2.6; 95% CI, 1.4-4.2). Long-term survivors after autologous HSCT are at an increased risk of death due to secondary cancers, infections, and any organ diseases as well as recurrence compared to the general population. When monitoring these patients in the outpatient clinic, it is important for physicians to predict a change in the patient's condition and to start treatment earlier.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine,Nagakute, Japan.
- Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
- Department of Hematology, St. Luke's International Hospital, Tokyo, Japan.
- Department of Hematology/Oncology, Osaka Women's and Children's Hospital, Osaka, Japan.
- Department of Pediatrics, Ehime Prefectural Central Hospital, Matsuyama, Japan.
- Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Zitieren
APA
Iida, M., Nakasone, H., Yamashita, T., Inoue, M., Ishida, Y., Uchiyama, H., Katayama, Y., Miyamoto, T., Yoshioka, S., Shiratori, S., Mori, T., Sawa, M., Sugio, Y., Fukuda, T., Ichinohe, T., Atsuta, Y., Inamoto, Y., & Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation (2020). Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation. BLOOD CELL THERAPY / The official journal of APBMT. https://doi.org/10.31547/bct-2019-011
Vancouver
Iida M, Nakasone H, Yamashita T, Inoue M, Ishida Y, Uchiyama H, et al. Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation. BLOOD CELL THERAPY / The official journal of APBMT. 2020. doi:10.31547/bct-2019-011
BibTeX
@article{Iida2020,
author = {Iida, Minako and Nakasone, Hideki and Yamashita, Takuya and Inoue, Masami and Ishida, Yasushi and Uchiyama, Hitoji and Katayama, Yuta and Miyamoto, Toshihiro and Yoshioka, Satoshi and Shiratori, Souichi and Mori, Takehiko and Sawa, Masashi and Sugio, Yasuhiro and Fukuda, Takahiro and Ichinohe, Tatsuo and Atsuta, Yoshiko and Inamoto, Yoshihiro and Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation, Late Effect and Quality of Life Working Group of the Japan Society for Hematopoietic Cell Transplantation},
title = {Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation},
journal = {BLOOD CELL THERAPY / The official journal of APBMT},
year = {2020},
doi = {10.31547/bct-2019-011}
}
EUVIMED